← All organizations

BioInvent International AB

For profitWebsite ↗

Also known as: BioInvent International AB

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 11, 2024

Timeline

1990s

Jun 1, 1996
BioInvent International AB— Founded

Drugs by trial phase (18 distinct, 19 trials)

Phase 2 (16 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (23)

NCT06784648Lead sponsorPhase 1/Phase 2Dec 11, 2024
NCT06205706OfficialPhase 1/Phase 2Dec 4, 2023
NCT06205706Lead sponsorPhase 1/Phase 2Dec 4, 2023
NCT05555251Study directorPhase 1/Phase 2Jul 28, 2022
NCT05555251Lead sponsorPhase 1/Phase 2Jul 28, 2022
NCT04725331CollaboratorPhase 1/Phase 2Feb 25, 2021
NCT04752826Lead sponsorPhase 1/Phase 2Jan 25, 2021
NCT04752826Study directorPhase 1/Phase 2Jan 25, 2021
NCT04219254Lead sponsorPhase 1/Phase 2Feb 29, 2020
NCT03571568Lead sponsorPhase 1/Phase 2May 16, 2018
NCT02756728Lead sponsorPhase 1/Phase 2May 1, 2016
NCT02748135CollaboratorPhase 1/Phase 2May 1, 2016
NCT01838369Lead sponsorPhase 2Mar 1, 2013
NCT01486823Lead sponsorPhase 1Nov 1, 2011
NCT01344954CollaboratorPhase 2Apr 1, 2011

Details

Founded: Lund, SE Jun 1, 1996
Last known activity: Dec 11, 2024